Medistim ASA (OSL:MEDI)
Norway flag Norway · Delayed Price · Currency is NOK
229.00
+3.00 (1.33%)
Aug 4, 2026, 4:25 PM CET

Medistim ASA Financials Overview

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
719.89699.77562.6526.36491.94427.28
Revenue Growth
17.95%24.38%6.88%7.00%15.13%17.66%
Gross Profit
581.05571.59448.92414.08385.45330.16
Operating Income
194.11196.2131.08131.44141.25116.28
Net Income
156.08159.21103.83103.82113.9790.9
Earnings Per Share
8.538.715.675.676.244.98
EPS Growth
27.12%53.62%0%-9.13%25.30%31.05%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PPP and Lease Revenue - Flow Procedures (PPP/Card Based)
54.8462.2761.3464.3761.1-
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based)
40.7140.7339.536.2432.69-
Capital Sales - Flow Systems
62.7659.9555.2255.5549.66-
Capital Sales - Flow and Imaging Systems
99.27119.1369.1781.4986.43-
Capital Sales - Flow Probes
257.93292.41231.47193.06169.18-
Capital Sales - Imaging Probes
19.17240.5416.0816.2317.04-
Third Party Products
99.85101.2489.8279.4375.8374.34
Revenue (Total)
634.52699.77562.6526.36491.94427.28

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
209.79212.09179.21153.87152.64129.49
Total Debt
34.649.2734.3617.6417.1124.19
Net Cash (Debt)
175.19162.82144.85136.23135.54105.3
Net Cash Growth
11.39%12.41%6.33%0.51%28.72%221.24%
Net Cash Per Share
9.598.917.917.457.425.77

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
179.97187.08143.1119.2113.49127.37
Capital Expenditures
--15.53-6.07-16.4-9.25-7.4
Free Cash Flow
179.97171.56137.04102.8104.24119.97
Free Cash Flow Growth
30.17%25.19%33.30%-1.38%-13.11%79.91%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
80.71%81.68%79.79%78.67%78.35%77.27%
Operating Margin
26.96%28.04%23.30%24.97%28.71%27.21%
Pretax Margin
28.01%29.56%23.86%25.69%29.69%26.70%
Profit Margin
21.68%22.75%18.46%19.72%23.17%21.27%
FCF Margin
25.00%24.52%24.36%19.53%21.19%28.08%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
8.0008.0006.0004.5004.5003.750
Dividend Per Share Growth
33.33%33.33%33.33%0%20.00%25.00%
Dividend Yield
3.54%2.31%3.01%2.10%1.62%0.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
26.8229.7426.3737.7437.0273.80
Forward PE
24.6329.1025.3433.8039.9461.56
P/FCF Ratio
24.6427.6820.0138.1740.6455.84
PS Ratio
5.826.794.877.468.6115.68